Professor Festenstein is an associate of the Medical Research Council's Clinical Sciences Centre (www.csc.mrc.ac.uk) a member of the Division of Brain Sciences and the Section of Translational Neurosciences, Imperial College and an Honorary Consultant at the Imperial College Health Care Trust and the National Hospital for Neurology and Neurosurgery, Queen Square, London.
Reversing FXN gene silencing in vivo in humans -towards a disease-modifying therapy?, International Ataxia Research Conference 2015, Windsor, 2015
Epigenetics and Disease: "Antagonising heterochromatin formation in Friedreich's ataxia: a novel therapy for a prototypic position-effect disease?", Gordon Reserach Conference on Epigenetics, Bryant University, Smithfield, Rhode Island, USA, 2013
Epigenetic mechanisms and genetic diseases, College de France, College de france, 2013
Gender bias and diseases: which genetic mechanisms?: Not just sex: Sex chromosome complement effects independent of phenotypic sex determine autosomal gene expression differences, College de France, College de France, Paris, France, 2011
Current Research into the Ataxias’ - FASI/Ataxia UK research conference: Breaking the Silence in Friedreich's ataxia, Ataxia UK/ FASI, Ataxi UK/FASI International Conference on Ataxia, The Stillorgan Park Hotel, Co. Dublin, Ireland., 2008